Carolyn Ng
Director at Odyssey Therapeutics.
Raised on Odyssey Therapeutics filings
$214M
of $214M offered across 1 Form D filing
- Form D filings
- 1
- Teammates
- 13
- Last filing
- Dec 4, 2025
Company
Transcription factor drugs for autoimmune disease
- Investors
- 55
- Founded
- 2021
Odyssey Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Dec 4, 2025 | Equity | $214M/ $214M | Form D |
- EquityFiled Dec 4, 2025Form D$214M/ $214M
Works with
Gary D. GlickPresident & CEO, Form D signerForm D signerJason HaasChief Financial Officerlan F. SmithDirectorCarl GordonDirectorJeffrey LeidenDirectorJill CarrollDirectorKsenija PavleticDirectorNan LiDirectorNia TatsisDirectorPaulina HillDirectorShelley ChuDirectorTimothy WalbertDirectorValerie OdegardDirector
